Sign in
4

Changes in Ownership

BIO-TECHNE Corp Filed Acc 0001062993-24-015997

Chief Executive Officer acquired 1,492 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Kelderman Kim Chief Executive Officer 2024-08-29 Option exercise +1,492 $66.97 $99,919 41,434 D
Derivatives
Kelderman Kim Chief Executive Officer 2024-08-29 Option exercise · Stock Option (Right to Buy) −1,492 115,724 D
Loading xslF345X05/form4.xml…